PillRx only · Solution · Oral
Baclofen
Brands: Ozobax Ds · Baclofen
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.618
Latest avg · Jul 22, 2026
-7%
Since Dec 17, 2025
6
Active US suppliers
54%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
7.5K
Rx · 2026 Q1
3.0M
Units dispensed
+86%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| ATLANTIC BIOLOGICALS CORP. | unknown | 4 | SUPPLYING |
| Advagen Pharma Ltd | unknown | 3 | SUPPLYING |
| Rosemont Pharmaceuticals LLC | unknown | 3 | SUPPLYING |
| Trifluent Pharma LLC | unknown | 1 | SUPPLYING |
| TRUPHARMA, LLC | unknown | 1 | SUPPLYING |
| Palmetto Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.